Study #2023-0407
CCTG-HN11: SPECT-CT Guided Elective Contralateral Neck Treatment [SELECT] for patients with lateralized Oropharyngeal Cancer: A phase III randomized controlled trial
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study is being done to answer the following question: Is the chance of cancer spreading or returning the same if radiotherapy to the neck is guided, by using a special imaging study called lymph node mapping (lymphatic mapping) Single Photon Emission Computed Tomography (SPECT-CT), compared to the usual treatment when radiotherapy is given to both sides of the neck?
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Oropharyngeal Cancer
Study phase:
Phase III
Physician name:
Anna Lee
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.